What are the risk factors for emphysematous cholecystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Emphysematous cholecystitis is primarily associated with diabetes mellitus, which is the most significant risk factor, along with other factors such as older age, male gender, and previous abdominal surgery. The risk factors for emphysematous cholecystitis can be identified as follows:

  • Diabetes mellitus: This is the most significant risk factor, as it impairs microcirculation and increases the risk of bacterial infection 1.
  • Older age: Typically over 50 years, as it increases the risk of compromised blood supply to the gallbladder 1.
  • Male gender: Associated with an increased risk of complications and conversion to open cholecystectomy, which may be related to increased skeletal muscle mass and visceral abdominal fat 1.
  • Previous abdominal surgery: A risk factor for conversion to open cholecystectomy due to intra-abdominal adhesions related to previous abdominal surgery 1.
  • Other factors: Such as peripheral vascular disease, immunocompromised states, gallstones, alcohol abuse, and conditions causing bile stasis or gallbladder ischemia, which can contribute to the development of emphysematous cholecystitis. The pathophysiology of emphysematous cholecystitis involves gas-forming bacteria infecting the gallbladder wall, leading to gas formation within the gallbladder lumen, wall, or surrounding tissues 1. This occurs due to compromised blood supply to the gallbladder in combination with bacterial infection, particularly in patients with impaired microcirculation from diabetes or vascular disease. Prompt recognition and treatment are essential, as emphysematous cholecystitis represents a severe, potentially life-threatening variant of acute cholecystitis with higher rates of gallbladder perforation and mortality compared to non-emphysematous cholecystitis 1.

From the Research

Risk Factors for Emphysematous Cholecystitis

The risk factors for emphysematous cholecystitis include:

  • Systemic disease, especially diabetes and vascular disease 2, 3
  • Arteriosclerosis and embolic events 3
  • Ischemia of the gallbladder wall with secondary gas-producing bacterial proliferation 4
  • Advanced age, with the condition being more common in elderly men 2

Associated Conditions

Emphysematous cholecystitis has been associated with:

  • Gas-forming organisms, such as Clostridium perfringens 3, 4
  • Acute cholecystitis, with emphysematous cholecystitis being a rare and severe form of the condition 5, 6
  • Emphysematous pancreatitis, with simultaneous occurrence of both conditions being possible 6

Demographics

The condition has been reported in various age groups, including:

  • A 24-year-old male without predisposing factors 2
  • A 46-year-old male with emphysematous cholecystitis due to Clostridium perfringens 3
  • An 83-year-old female patient successfully treated by laparoscopic surgery 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Emphysematous Cholecystitis in 24-Year-old Male Without Predisposing Factors.

Journal of clinical and diagnostic research : JCDR, 2015

Research

A case of emphysematous cholecystitis managed by laparoscopic surgery.

JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2005

Research

The changing face of emphysematous cholecystitis.

The British journal of radiology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.